Add time:08/16/2019 Source:sciencedirect.com
A series of N-guanidino substituted 2,4-diamino-5-carbonylguanidine molecules related to amiloride were synthesised and evaluated for their ability to inhibit the sodium–calcium exchanger in rat insulinoma cells (RINm5F) and human platelets. Specific chemical pathways were used to prepare the benzene derivatives designed as bioisosteric analogues of the pyrazine derivatives of amiloride. Several so-called ‘simplified analogues’, where some substituents of amiloride were omitted or replaced, were also prepared and included in the biological evaluation. The inhibitory potency of the sodium–calcium exchanger was screened on both cell types by measuring their effect on 45Ca2+ uptake. Among the most active compounds, N-(2-amino-5-chloro-4-nitrobenzoyl)-N′-(1-naphtylmethyl)guanidine (IC50=3.4 μM) was found more active than amiloride (IC50=690 μM) and 3,4-dichlorobenzamil (IC50=15.2 μM), the reference inhibitor.
We also recommend Trading Suppliers and Manufacturers of 2-Chloro-N-[4-chloro-2-(2-chlorobenzoyl)phenyl]acetamide (cas 14405-03-9). Pls Click Website Link as below: cas 14405-03-9 suppliers
About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia
Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog
©2008 LookChem.com,License: ICP
NO.:Zhejiang16009103
complaints:service@lookchem.com Desktop View